Vimarsana
Biggest News Aggregation in the World

Compartmentc Euronext News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compartmentc Euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compartmentc Euronext Today - Breaking & Trending Today

Akkadian Partners SA: Akkadian Partners Fund has Acquired Over a 5% Shareholding and Voting Rights in Erytech and Intends to Vote Against the Merger between Erytech and Pherecydes - Vimarsana News

Akkadian Partners SA: Akkadian Partners Fund has Acquired Over a 5% Shareholding and Voting Rights in Erytech and Intends to Vote Against the Merger between Erytech and Pherecydes

Published: May 16, 2023

PARIS, FRANCE/ ACCESSWIRE / May 16, 2023 / Akkadian Partners SA ("Akkadian") has announced that Akkadian Partners Fund, a Luxemburg registered securitisation fund under its management, now holds over a

Source: finanznachrichten.de
Related Topics:
France GeneralUnited StatesFranck LescureGil BeyenDidier HochGewinn NurErytech PherecydePherecydes PharmaArmata Pharmaceuticals New York Stock ExchangeAkkadian Partners FundUltra High Network Investors UhnwisAkkadian PartnersGeneral AssemblyElaia PartnersAuriga VenturesCompassionate Access AuthorisationsNew York Stock ExchangePhage TherapeuticsMayo ClinicCompartmentc EuronextEuronext GrowthAuriga PartnersMonsieur FranckFamily OfficesUltra High Network Investors
AKKADIAN PARTNERS: Akkadian Partners Fund has acquired over a 5% shareholding and voting rights in Erytech - Vimarsana News

AKKADIAN PARTNERS: Akkadian Partners Fund has acquired over a 5% shareholding and voting rights in Erytech

Published: May 12, 2023

Paris - 12 May 2023 - 6pm - Akkadian Partners SA ("Akkadian") has announced that Akkadian Partners Fund, a Luxemburg registered securitisation fund under its management, now holds over a 5% shareholding

Source: finanznachrichten.de
Related Topics:
United StatesFrance GeneralPherecydes PharmaGil BeyenDidier HochErytech PherecydeFranck LescureUltra High Network Investors UhnwisArmata Pharmaceuticals New York Stock ExchangeAkkadian Partners FundGeneral AssemblyElaia PartnersAuriga VenturesCompassionate Access AuthorisationsNew York Stock ExchangePhage TherapeuticsMayo ClinicCompartmentc EuronextEuronext GrowthAuriga PartnersMonsieur FranckFamily OfficesUltra High Network InvestorsGefallene Big Techs